An anti-endotoxin peptide that generates from the amino-terminal domain of complement regulatory protein C1 inhibitor

Biochemical and Biophysical Research Communications

Volumn 359, Issue 2, 2007, Pages 285-291

  Zhang, Haimou ^a   Li, Jinan ^b   Barrington, Robert A ^b   Liang, Gang ^c   Qin, Gangjian ^d   Liu, Dong xu ^a  

^a HUBEI UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Complement; Inflammation; Peptide

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; ENDOTOXIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; SEPTIC SHOCK;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD14; COMPLEMENT C1 INHIBITOR PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; SHOCK; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); MURINAE; MUS; NEGIBACTERIA;

EID: 34249943568     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.078     Document Type: Article

References (28)

1. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
2. Akashi S., Saitoh S., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y., Kusumoto Y., Fukase K., Kusumoto S., Adachi Y., Kosugi A., and Miyake K. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198 (2003) 1035-1042
3. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., and Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3 (2002) 667-672
4. Beutler B., Milsark I.W., and Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229 (1985) 869-871
5. Mathison J.C., Wolfson E., and Ulevitch R.J. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81 (1988) 1925-1937
6. Nassif X., Mathison J.C., Wolfson E., Koziol J.A., Ulevitch R.J., and So M. Tumour necrosis factor alpha antibody protects against lethal meningococcaemia. Mol. Microbiol. 6 (1992) 591-597
7. Aketagawa J., Miyata T., Ohtsubo S., Nakamura T., Morita T., Hayashida H., Miyata T., Iwanaga S., Takao T., and Shimonishi Y. Primary structure of limulus anticoagulant anti-lipopolysaccharide factor. J. Biol. Chem. 261 (1986) 7357-7365
8. Hoess A., Watson S., Siber G.R., and Liddington R. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution. EMBO J. 12 (1993) 3351-3356
9. Little R.G., Kelner D.N., Lim E., Burke D.J., and Conlon P.J. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J. Biol. Chem. 269 (1994) 1865-1872
10. Taylor A.H., Heavner G., Nedelman M., Sherris D., Brunt E., Knight D., and Ghrayeb J. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 270 (1995) 17934-17938
11. Liu D., Cai S., Gu X., Scafidi J., Wu X., and Davis III A.E. C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J. Immunol. 171 (2003) 2594-2601
12. Tobias P.S., Soldau K., and Ulevitch R.J. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264 (1989) 10867-10871
13. Bock S.C., Skriver K., Nielsen E., Thogersen H.C., Wiman B., Donaldson V.H., Eddy R.L., Marrinan J., Radziejewska E., Huber R., et al. Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry 25 (1986) 4292-4301
14. Larrick J.W., Hirata M., Balint R.F., Lee J., Zhong J., and Wright S.C. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63 (1995) 1291-1297
15. Wilde C.G., Seilhamer J.J., McGrogan M., Ashton N., Snable J.L., Lane J.C., Leong S.R., Thornton M.B., Miller K.L., Scott R.W., et al. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation. J. Biol. Chem. 269 (1994) 17411-17416
16. Liu D., Cramer C.C., Scafidi J., and Davis III A.E. N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A. Infect. Immun. 73 (2005) 4478-4487
17. Liu D., Gu X., Scafidi J., and Davis III A.E. N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice. Infect. Immun. 72 (2004) 1946-1955
18. Brower M.S., and Harpel P.C. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. J. Biol. Chem. 257 (1982) 9849-9854
19. Nuijens J.H., Eerenberg-Belmer A.J., Huijbregts C.C., Schreuder W.O., Felt-Bersma R.J., Abbink J.J., Thijs L.G., and Hack C.E. Proteolytic inactivation of plasma C1-inhibitor in sepsis. J. Clin. Invest. 84 (1989) 443-450
20. Jacob H.S., Craddock P.R., Hammerschmidt D.E., and Moldow C.F. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N. Engl. J. Med. 302 (1980) 789-794
21. Wachtfogel Y.T., Pixley R.A., Kucich U., Abrams W., Weinbaum G., Schapira M., and Colman R.W. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood 67 (1986) 1731-1737
22. Wachtfogel Y.T., Kucich U., James H.L., Scott C.F., Schapira M., Zimmerman M., Cohen A.B., and Colman R.W. Human plasma kallikrein releases neutrophil elastase during blood coagulation. J. Clin. Invest. 72 (1983) 1672-1677
23. Caliezi C., Wuillemin W.A., Zeerleder S., Redondo M., Eisele B., and Hack C.E. C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol. Rev. .52 (2000) 91-112
24. Catanese J., and Kress L.F. Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase. Biochim. Biophys. Acta 789 (1984) 37-43
25. Appelmelk B.J., An Y.Q., Geerts M., Thijs B.G., de Boer H.A., MacLaren D.M., de Graaff J., and Nuijens J.H. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62 (1994) 2628-2632
26. Ferguson A.D., Welte W., Hofmann E., Lindner B., Holst O., Coulton J.W., and Diederichs K. A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins. Structure 8 (2000) 585-592
27. Frecer V., Ho B., and Ding J.L. Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action. Eur. J. Biochem. 267 (2000) 837-852
28. Pristovsek P., and Kidric J. Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. J. Med. Chem. 42 (1999) 4604-4613